Dr. Ankit Mahadevia is an author, speaker, and biotech industry leader who serves as CXO of Curie.Bio. His venture capital enterprise invests in disruptive companies with unique technologies, and provides them with strategic guidance within a competitive and fast-evolving market. Dr. Ankit Mahadevia also holds advisory roles with Oath and Inductive Bio, and is on the board of the life sciences innovator Judo Bio.
Dr. Mahadevia has co-founded nine biotech companies, including Synlogic Therapeutics, Translate, and Spero Therapeutics. Building teams of highly competent managers, he has raised more than $1 billion toward breakthrough drugs. Consistent results earned him recognition as #15 nationwide in Glassdoor’s “Top 50 CEOs of 2021.” Dr. Mahadevia has presented in diverse academic forums, including Northwestern University, Harvard University, and the Berkeley Forum.
Dr. Mahadevia’s well-received book Quiet Leader, Loud Results (Post Hill Press, 2022) is grounded in personal experience and reflects his experience as a leader who overcame a sense of being underestimated in environments that were loud and fast-paced. He provides a template for maintaining authenticity to the introverted aspects of one’s personality, while simultaneously advancing in public leadership.